- Conditions
- Healthy
- Interventions
- AMD3100 (Mozobil plerixafor)
- Drug
- Lead sponsor
- National Heart, Lung, and Blood Institute (NHLBI)
- NIH
- Eligibility
- 18 Years to 80 Years
- Enrollment
- 8 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2004 – 2012
- U.S. locations
- 1
- States / cities
- Bethesda, Maryland
Source: ClinicalTrials.gov public record
Updated Feb 6, 2018 · Synced May 22, 2026, 5:05 AM EDT